Regarding GBO's ownership, potential delisting and the proposed rights issue
Greiner Bio-One GmbH ("GBO") has informed Vigmed Holding AB (publ) ("Vigmed") of the following. As of 3 July 2017, GBO owns 89.54 percent of all shares in Vigmed. GBO's ownership in Vigmed has increased quicker than expected since Vigmed's decision to propose a new issue of shares with preferential rights for the company's shareholders. GBO has further informed that GBO intends to continue to purchase shares in the market until GBO obtains an ownership of more than 90 percent of all shares in Vigmed. In view of GBO's current rate of acquiring Vigmed shares, it is not unlikely that GBO